230 related articles for article (PubMed ID: 1091827)
1. [Anti-atelectasis factor (surfactant) and hyaline membrane disease in premature infants].
Saule H
Med Klin; 1975 Mar; 70(10):409-15. PubMed ID: 1091827
[No Abstract] [Full Text] [Related]
2. The circulation, fluid transfers and surface activity in the lungs of infants with hyaline membrane disease.
Normand IC
Bull Physiopathol Respir (Nancy); 1973; 9(6):1473-94. PubMed ID: 4602246
[No Abstract] [Full Text] [Related]
3. Respiratory distress syndrome in the tiny baby.
Fawcett WA; Gluck L
Clin Perinatol; 1977 Sep; 4(2):411-23. PubMed ID: 332436
[No Abstract] [Full Text] [Related]
4. [Pulmonary hyaline membranes in newborn infants. (Idiopathic respiratory distress syndrome)].
Göcke H; Bienengräber A
Zentralbl Chir; 1974 Aug; 99(34):1057-61. PubMed ID: 4613061
[No Abstract] [Full Text] [Related]
5. [Factors increasing susceptibility to neonatal hyaline membrane syndrome and its prevention. I. Deficiency of surfactant and glucocorticoid treatment].
Uszyńska-Folejewska R; Uszyński M
Pediatr Pol; 1977 Dec; 52(12):1413-7. PubMed ID: 343058
[No Abstract] [Full Text] [Related]
6. [Importance of the "surfactant system" in the pathogenesis of hyaline membrane in the newborn].
Cosmi EV; Condorelli S; Scarpelli EM
Acta Anaesthesiol; 1970; 31():Suppl:69-94. PubMed ID: 5538013
[No Abstract] [Full Text] [Related]
7. The adrenal cortex, steroids, and hyaline membrane disease.
Reynolds JW
Pediatrics; 1971 Apr; 47(4):645-6. PubMed ID: 5108824
[No Abstract] [Full Text] [Related]
8. [Surface-active factor of the lungs (surfactant) in certain diseases of the respiratory organs].
Puchkov GF; Iazvinskiĭ II
Sov Med; 1975 Aug; (8):62. PubMed ID: 1105810
[No Abstract] [Full Text] [Related]
9. The first expiration: role of pulmonary surfactant.
Chernick V
Semin Perinatol; 1977 Oct; 1(4):351-5. PubMed ID: 382368
[No Abstract] [Full Text] [Related]
10. The effects of surfactant and antenatal corticosteroid treatment on the pulmonary pathology of preterm infants with respiratory distress syndrome.
Teksam O; Kale G
Pathol Res Pract; 2009; 205(1):35-41. PubMed ID: 18951732
[TBL] [Abstract][Full Text] [Related]
11. [Study of fetal alveolar surfactant: possibility of induction].
Bracaglia R; Bellati U; Serri F; Garzetti GG
Clin Ter; 1979 Dec; 91(6):593-606. PubMed ID: 44494
[No Abstract] [Full Text] [Related]
12. [Pulmonary surfactant in neonatal pathology].
Artus JC; Benezech C; Llory J; Bonnet H; Lesbros D
Ann Anesthesiol Fr; 1976; 17(1):19-28. PubMed ID: 990049
[TBL] [Abstract][Full Text] [Related]
13. [Critical study of the use of glucocorticoids in the prevention of hyaline membrane disease].
Leroy JL
J Gynecol Obstet Biol Reprod (Paris); 1982; 11(1):152-7. PubMed ID: 6896522
[No Abstract] [Full Text] [Related]
14. Cellular and biochemical aspects of pulmonary surfactant in health and disease.
Kikkawa Y; Smith F
Lab Invest; 1983 Aug; 49(2):122-39. PubMed ID: 6348405
[No Abstract] [Full Text] [Related]
15. [Treatment of hyaline membrane disease by administration of exogenous surfactant].
Bonte F; Dehan M; de Fontanges A; Lindenbaum A; Perret L; Puisieux F
Arch Fr Pediatr; 1985 May; 42(5):397-402. PubMed ID: 3907577
[No Abstract] [Full Text] [Related]
16. [For or against the early use of nasal continuous positive pressure and exogenous surfactant in hyaline membrane disease. Physiopathologic arguments].
Storme L; Truffert P; Rakza T; Lequien P
Arch Pediatr; 1999 May; 6(5):549-55. PubMed ID: 10370813
[TBL] [Abstract][Full Text] [Related]
17. Adrenal gland structure and the development of hyaline membrane disease.
Naeye RL; Harcke HT; Blanc WA
Pediatrics; 1971 Apr; 47(4):650-7. PubMed ID: 5109055
[No Abstract] [Full Text] [Related]
18. A model of the effect of surfactant treatment on gas exchange in hyaline membrane disease.
Cotton RB
Semin Perinatol; 1994 Feb; 18(1):19-22. PubMed ID: 8209282
[No Abstract] [Full Text] [Related]
19. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants.
Liggins GC; Howie RN
Pediatrics; 1972 Oct; 50(4):515-25. PubMed ID: 4561295
[No Abstract] [Full Text] [Related]
20. [The therapeutic use of pulmonary surfactant in neonatal hyaline membrane disease].
Lozano-González CH; Piña-Ceballos VM; Beyer-Obezo J; Gutiérrez-Martín A; Martínez-Hinojosa B; Flores-Támez ME
Bol Med Hosp Infant Mex; 1993 Jul; 50(7):481-91. PubMed ID: 8363747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
